Binance We will be listing Centrifuge (CFG) and offering a variety of trading services.
Svmuu News: According to an official announcement, Binance will list Centrifuge (CFG) and launch multiple services on March 16, 2026, at 13:00 (UTC).Specifically: CFG will be listed on Binance’s SimpleEarn flexible product; users can purchase CFG via credit card and other methods on the “Buy” page; Binance’s Flash Swap will support zero-fee trading between CFG and BTC, USDT, and other assets;CFG will be listed as a borrowable asset on VIP Lending. Additionally, Binance’s margin trading will add CFG as a borrowable asset in both cross-margin and isolated-margin modes at that time, and will launch CFG/USDT and CFG/USDC trading pairs; portfolio margin trading will also be supported simultaneously.Furthermore, Binance will launch U-denominated CFG perpetual contracts (CFGUSDT) at the same time, supporting up to 50x leverage, and will open copy trading for these contracts within 24 hours. (This news update was generated with AI assistance)
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
5
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
6
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
9
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
10
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
Markets Today
Recommended Reading







